| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.2M | +165.0% |
| Cost of Revenue | $19.2M | +218.2% |
| Gross Profit | $6.0M | +73.0% |
| R&D Expense | $2.7M | -25.2% |
| SG&A Expense | $10.7M | +35.7% |
| Operating Income | -$7.3M | +13.2% |
| Pre-tax Income | -$7.0M | +37.7% |
| Income Tax | $13K | -13.3% |
| Net Income | -$7.0M | +37.7% |
| EPS (Basic) | -$0.33 | +69.4% |
| EPS (Diluted) | -$0.33 | +69.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | -74.2% |
| Accounts Receivable | $3.3M | +166.5% |
| Inventory | $8.9M | +17.4% |
| Current Assets | $25.1M | -11.5% |
| Total Assets | $51.5M | +19.1% |
| Current Liabilities | $14.9M | +870.5% |
| Total Liabilities | $18.6M | +224.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.7M | -64.0% |
| Capital Expenditures | $1.0M | +2266.5% |
| Investing Cash Flow | -$5.8M | -74.8% |
| Financing Cash Flow | $6.8M | -67.8% |
| Free Cash Flow | -$9.7M | -81.7% |
| $32.9M |
| -12.3% |